Found: 1
Select item for more details and to access through your institution.
Efbemalenograstim alfa not inferior to pegfilgrastim in providing neutrophil support in women with breast cancer undergoing myelotoxic chemotherapy: results of a phase 2 randomized, multicenter, open-label trial.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 2, p. 1, doi. 10.1007/s00520-023-08260-x
- By:
- Publication type:
- Article